Hidradenitis suppurativa trials in Georgia

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  Where

  Tbilisi

  Age

  18 years to 70 years

  People

  150 worldwide

  Run by

  Navigator Medicines, Inc.

  See details and how to joinNCT07384975 · EU 2025-523557-33-00